chr20-3689196-C-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_023068.4(SIGLEC1):āc.5029G>Cā(p.Glu1677Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_023068.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SIGLEC1 | NM_023068.4 | c.5029G>C | p.Glu1677Gln | missense_variant | 21/22 | ENST00000344754.6 | |
SIGLEC1 | NM_001367089.1 | c.4997+404G>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SIGLEC1 | ENST00000344754.6 | c.5029G>C | p.Glu1677Gln | missense_variant | 21/22 | 1 | NM_023068.4 | P2 | |
SIGLEC1 | ENST00000419548.4 | c.*710G>C | 3_prime_UTR_variant | 5/5 | 2 | ||||
SIGLEC1 | ENST00000707083.1 | c.4997+404G>C | intron_variant | A2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251478Hom.: 0 AF XY: 0.000250 AC XY: 34AN XY: 135910
GnomAD4 exome AF: 0.000101 AC: 147AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.000110 AC XY: 80AN XY: 727240
GnomAD4 genome AF: 0.000105 AC: 16AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2022 | The c.5029G>C (p.E1677Q) alteration is located in exon 20 (coding exon 20) of the SIGLEC1 gene. This alteration results from a G to C substitution at nucleotide position 5029, causing the glutamic acid (E) at amino acid position 1677 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2022 | SIGLEC1: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at